Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tri Vobimeal 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Seluria Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Tri Vobimeal 2mg/500mg/0.2mg Tablet

Combiflex DM 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Combiflex DM 2mg/500mg/0.2mg tablets should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and carry readily available glucose sources, such as sugary snacks or juice. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Tri Vobimeal 2mg/500mg/0.2mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Tri Vobimeal 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Tri Vobimeal 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Tri Vobimeal 2mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.

Common Side effects of Tri Vobimeal 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Tri Vobimeal 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tri Vobimeal 2mg/500mg/0.2mg Tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.

How Tri Vobimeal 2mg/500mg/0.2mg Tablet works:

Each Tri Vobimeal 2mg/500mg/0.2mg tablet contains a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tri Vobimeal 2mg/500mg/0.2mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Tri Vobimeal 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tri Vobimeal 2mg/500mg/0.2mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Tri Vobimeal 2mg/500mg/0.2mg tablets pose a likely risk to individuals with kidney impairment and should be omitted. Physician consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Tri Vobimeal 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is usually prescribed for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Tri Vobimeal 2mg/500mg/0.2mg Tablet :

Should you forget a Tri Vobimeal 2mg/500mg/0.2mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tri Vobimeal 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Tri Vobimeal 2mg/500mg/0.2mg Tablet

Tri Vobimeal 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is unsuitable for type 1 diabetes.
Tri Vobimeal 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, rash, and respiratory infection.
Tri Vobimeal 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to any ingredient, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Tri Vobimeal 2mg/500mg/0.2mg Tablets with alcohol is unsafe. This combination may worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Tri Vobimeal 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Tri Vobimeal 2mg/500mg/0....
100
MRP 116
13% off